Effects of Liraglutide on GLP-1, GIP and glucagon concentrations in persons with type 2 diabetes with multiple daily insulin injections during a 24-week period

被引：0
|
作者：
Koci, M. [1 ]
Jansson, P. -A. [2 ]
Fatulla, P. [2 ]
Bergqvist, K. [3 ]
Ahmadi, S. Seyed [2 ]
Imberg, H. [2 ]
Hirsch, I. [4 ]
Mellander, O. [5 ]
Lind, M. [2 ]
机构：
[1] Sahlgrens Univ Hosp, Dept Endocrinol & Diabet, Gothenburg, Sweden
[2] Gothenburg Univ, Dept Mol & Clini cal Med, Gothenburg, Sweden
[3] Gothenburg Univ, Dept Infect Dis, Gothenburg, Sweden
[4] UW Med Diabet Inst, Div Metab Endocrinol & Nutr, Seattle, WA USA
[5] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
83
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] Effects of Liraglutide on GLP-1, GIP, and Glucagon Concentrations in Persons with Type 2 Diabetes with Multiple Daily Insulin Injections during a 24-Week Period
    Koci, Marsel
    Hirsch, Irl B.
    Ahmadi, Shilan Seyed
    Lind, Marcus
    DIABETES, 2024, 73
  • [2] Evaluation of GLP-1 Receptor Agonists in Combination With Multiple Daily Insulin Injections for Type 2 Diabetes
    Sassenrath, Kimberly
    Phillips, Beth Bryles
    Stone, Rebecca H.
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (06) : 979 - 990
  • [3] Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
    Westman, Klara
    Imberg, Henrik
    Wijkman, Magnus O.
    Hirsch, Irl B.
    Tuomilehto, Jaakko
    Dahlqvist, Sofia
    Lind, Marcus
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (03)
  • [4] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
    Ryan, Gina J.
    Hardy, Yolanda
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
  • [5] Effect of liraglutide on time in various glycaemic ranges in persons with type 2 diabetes treated with multiple daily insulin injections
    Sofizadeh, S.
    Olafsdottir, A. F.
    Dahlqvist, S.
    Hirsch, I. B.
    Tuomilehto, J.
    Lind, M.
    DIABETOLOGIA, 2017, 60 : S386 - S386
  • [6] The Separate and Combined Impact of the Intestinal Hormones, GIP, GLP-1 and GLP-2, on Glucagon Secretion in Type 2 Diabetes
    Lund, Asger
    Vilsb'Oll, Tina
    Bagger, Jonatan Issing
    Holst, Jens Juul
    Knop, Filip Krag
    DIABETES, 2010, 59 : A75 - A75
  • [7] The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
    Lund, Asger
    Vilsboll, Tina
    Bagger, Jonatan I.
    Holst, Jens J.
    Knop, Filip K.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (06): : E1038 - E1046
  • [8] The separate and combined impact of the intestinal hormones GIP, GLP-1 and GLP-2 on glucagon secretion in type 2 diabetes
    Lund, A.
    Vilsboll, T.
    Bagger, J. I.
    Holst, J. J.
    Knop, F. K.
    DIABETOLOGIA, 2010, 53
  • [9] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
    Vilsboll, Tina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
  • [10] The impact of GLP-1 analogue liraglutide on type 2 diabetes patients with and without insulin therapy
    Haq, Z.
    Reidy, Y.
    Dempsey, M.
    Reidy, C.
    Keogh, A. M.
    Hoashi, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S491 - S492
12345